Narrow search
Showing 1 - 10 of 114
Cover Image
Harmonizing regulatory market approval of products with high safety requirements : evidence from the European pharmaceutical market
Grünwald, Fabian; Stargardt, Tom - In: Health economics 33 (2024) 7, pp. 1546-1564
Persistent link: https://www.econbiz.de/10014566060
Cover Image
Free medicines thanks to retirement : impact of coinsurance exemption on pharmaceutical expenditures and hospitalization offsets in a national health service
Puig-Junoy, Jaume; García Gómez, Pilar; Casado Marin, … - In: Health economics 25 (2016) 6, pp. 750-767
Persistent link: https://www.econbiz.de/10011542205
Cover Image
Pharmaceutical pricing in emerging markets : effects of income, competition, and procurement
Danzon, Patricia Munch; Mulcahy, Andrew W.; Towse, Adrian K. - In: Health economics 24 (2015) 2, pp. 238-252
Persistent link: https://www.econbiz.de/10011317852
Cover Image
The determinants of pricing in pharmaceuticals : are US prices really so high?
Cabrales, Antonio; Jiménez-Martín, Sergi - In: Health economics 22 (2013) 11, pp. 1377-1397
Persistent link: https://www.econbiz.de/10010242974
Cover Image
Reconciling estimates of the value to firms of reduced regulatory delay in the marketing of their new drugs
Wilmoth, Daniel R. - In: Health economics 24 (2015) 12, pp. 1651-1656
Persistent link: https://www.econbiz.de/10011486883
Cover Image
Effects of the German reference drug program on ex-factory prices of prescription drugs : a panel data approach
Augurzky, Boris; Göhlmann, Silja; Greß, Stefan; … - In: Health economics 18 (2009) 4, pp. 421-436
Persistent link: https://www.econbiz.de/10003844289
Cover Image
External referencing and pharmaceutical price negotiation
García-Mariñoso, Begoña; Jelovac, Izabela; Olivella, Pau - In: Health economics 20 (2011) 6, pp. 737-756
Persistent link: https://www.econbiz.de/10009129628
Cover Image
More cost-sharing, less cost? : evidence on reference price drugs
Herr, Annika; Stühmeier, Torben; Wenzel, Tobias - In: Health economics 32 (2023) 2, pp. 413-435
Persistent link: https://www.econbiz.de/10014266816
Cover Image
Therapeutic substitution post-patent expiry : the cases of ACE inhibitors and proton pump inhibitors
Vandoros, Sotris - In: Health economics 23 (2014) 5, pp. 621-630
Persistent link: https://www.econbiz.de/10011305497
Cover Image
The January effect: medication reinitiation among Medicare part D beneficiaries
Kaplan, Cameron; Zhang, Yuting - In: Health economics 23 (2014) 11, pp. 1287-1300
Persistent link: https://www.econbiz.de/10011308176